Use of cisplatin, 5-fluorouracil, and second-look laparotomy for the management of gastrointestinal adenocarcinoma in three dogs

Journal of the American Veterinary Medical Association

Volumn 225, Issue 9, 2004, Pages 1412-1417

  Stanclift, Rebecca M ^a,b   Gilson, Stephen D ^a  

^a Sonora Veterinary Specialists   (United States)

^b RED BANK VETERINARY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTORPHANOL; CARBOPLATIN; CISPLATIN; DEXAMETHASONE SODIUM PHOSPHATE; DOXORUBICIN; FLUOROURACIL;

ABDOMINAL ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; DOG; DRUG EFFICACY; DRUG USE; FEMALE; GASTROINTESTINAL CARCINOMA; HISTOLOGY; LYMPH NODE METASTASIS; MALE; NONHUMAN; PHYSICAL EXAMINATION; REMISSION; SECOND LOOK SURGERY; SURVIVAL TIME; THORAX RADIOGRAPHY;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOGS; FEMALE; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; LAPAROTOMY; MALE; NEOPLASM RECURRENCE, LOCAL; REOPERATION; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 7444225137     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.225.1412     Document Type: Article

References (38)

1. Chun R, Garrett L, MacEwen EG. Cancer chemotherapy. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;92-118.
2. Magne ML. Gastrointestinal neoplasia. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII: small animal practice. Philadelphia: WB Saunders Co, 2000;622-624.
3. Phillips BS. Tumors of the intestinal tract. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;335-346.
4. Crawshaw J, Berg J, Sardinas JC, el al. Prognosis for dogs with nonlymphomatous tumors treated by surgical excision. J Am Anim Hosp Assoc 1998;34:451-456.
5. Withrow SJ. Gastric cancer. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;323-327.
6. Sellon RK, Bissonnette K, Bunch SE. Long-term survival after total gastrectomy for gastric adenocarcinoma in a dog. J Vet Intern Med 1996;10:333-335.
7. Alexander HR, Kelsen DP, Tepper JE. Cancer of the stomach. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997;1021-1054.
8. Wangensteen OH. Experience with cancer of the stomach and colon and second look procedure. Minn Med 1968;51:1833-1838.
9. Wangensteen OH, Sosin H. How can the outlook in alimentary tract cancer be improved? Am J Surg 1968;115:7-16.
10. Low VH, Levine MS, Rubesin SE, et al. Diagnosis of gastric carcinoma: sensitivity of double-contrast barium studies. AJR Am J Roentgenol 1994;162:329-334.
11. Ciresi DL, Scholten DJ. The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 1995;61:698-703.
12. Szarka C, Frucht H. Stomach and small bowel cancer. In: Harvey JC, Beattie EJ, eds. Cancer surgery. Philadelphia: WB Saunders Co, 1996;3-87.
13. Murad AM, Petroianu A, Guimaraes R, et al. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe and effective regimen. Am J Clin Oncol 1999;22:580-586.
14. De Franco A, Celi G, Restaino G, et al. Imaging of small bowel tumors. Rays 2002;27:35-50.
15. Kubik-Huch RA, Dorffler W, von Schulthess GK, et al. Value of (18F)-FDG positron emission tomography, computed tomography and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 2000;10:761-767.
16. Clarke-Pearson DL, Bandy LC, Dudzinski M, et al. Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. JAMA 1986;255:627-630.
17. Johnson K, Bakhsh A, Young D, et al. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 2001;44:354-357.
18. Falk PM, Gupta NC, Thorson AG, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37:153-156.
19. Collier BD, Foley WD. Current imaging strategies for colorectal cancer. J Nucl Med 1993;34:537-540.
20. Niloff JM, Goodman HM. Gynecologic oncology. In: Steele G, Cady B, eds. General surgical oncology. Philadelphia: WB Saunders Co, 1992;309-316.
21. Salom E, Almeida Z, Mirhashemi R. Management of recurrent ovarian cancer: evidence-based decisions. Curr Opin Oncol 2002;14:519-527.
22. Morrow PC. An opinion in support of second-look surgery in ovarian cancer. Gynecol Oncol 2000;79:341-343.
23. Lund B, Jacobsen K, Rasch L, et al. Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinoma. Gynecol Oncol 1990;37:279-283.
24. Rogalla P, Meiri N, Ruckert JC, et al. Colonography using multislice CT. Eur J Radiol 2000;36:81-85.
25. Kurtz AB, Tsimikas JV, Tempany CMC, et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis - report of the Radiology Diagnostic Oncology Group. Radiology 1999;212:19-27.
26. Chezmar JL, Rumancik WM, Megibow AJ, et al. Liver and abdominal screening in patients with cancer: CT versus MR imaging. Radiology 1988;168:43-47.
27. Hakim NS, Sarr MG, van Heerden JA. Does endoscopy really help the surgeon evaluate gastric cancer? Can J Surg 1989;32:175-177.
28. Berglund A, Molin D, Larsson A, et al. Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma. Ann Oncol 2002;13:1430-1437.
29. Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg 2001;234:198-205.
30. Gadducci A, Iacconi P, Fanucchi A, et al. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Anticancer Res 2000;20:1959-1964.
31. Jacobs AJ, Jennings TS. Cancer of the ovary and fallopian tube. In: Harvey JC, Beattie EJ, eds. Cancer surgery. Philadelphia: WB Saunders Co, 1996;423-438.
32. Ellis H, Jayasekara G. Is 'second look surgery' justified in suspected recurrences of cancer of the stomach? Br J Surg 1975;62:226-230.
33. Obermair A, Sevelda P. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Acta Obstet Gynecol Scand 2001;80:432-436.
34. Sijmons EA, Heintz AP Second-look and second surgery: second chance or second best? Semin Surg Oncol 2000;19:54-61.
35. Pullin JG. Holmium: YAG laser-assisted capsular shift in a canine model: intraarticular pressure and histologic observations. J Shoulder Elbow Surg 1997;6:272-285.
36. Gamal EM, Metzger P, Miko I, et al. The judgement of adhesion formation following laparoscopic and conventional cholecystectomy in an animal model. Acta Chir Hung 1999;38:169-172.
37. Boure L, Foster RA, Palmer M, et al. Use of an endoscopic suturing device for laparoscopic resection of the apex of the bladder and umbilical structures in normal and neonatal calves. Vet Surg 2001;30:319-326.
38. Gilson SD. Principles of surgery for cancer palliation and treatment of metastases. Clin Tech Small Anim Pract 1998;13:65-69.